Trials / Conditions / Adjuvant Chemotherapy

Adjuvant Chemotherapy

26 registered clinical trials studyying Adjuvant Chemotherapy — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer NCT07366528	Ruijin Hospital	Phase 3
Recruiting	A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cance NCT07136077	M.D. Anderson Cancer Center	Phase 2
Recruiting	Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally A NCT06949033	Zuoyi Jiao	Phase 3
Recruiting	Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined Wit NCT06925243	Zuoyi Jiao	Phase 3
Recruiting	Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer P NCT06389552	HK inno.N Corporation	—
Unknown	Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo NCT05613465	Zhejiang Provincial People's Hospital	N/A
Recruiting	Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer NCT05735145	Fourth Affiliated Hospital of Guangxi Medical University	Phase 3
Active Not Recruiting	New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy NCT04564157	Fundación GECP	Phase 3
Unknown	Adjuvant Chemotherapy in High Risk Stage II Colon Cancer NCT04303429	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 3
Withdrawn	Apatinib for Resectable Colorectal Cancer NCT03228043	Nanchong Central Hospital	N/A
Terminated	A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan NCT04070313	TTY Biopharm	Phase 2
Recruiting	Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosi NCT03748485	Sixth Affiliated Hospital, Sun Yat-sen University	N/A
Terminated	Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer NCT03702868	Sun Yat-sen University	—
Unknown	IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative NCT03748680	Karen-Lise Garm Spindler	Phase 2
Unknown	A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer NCT03468010	Sun Yat-sen University	Phase 3
Unknown	SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients NCT03448549	Peking University Cancer Hospital & Institute	Phase 3
Terminated	Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovari NCT03858166	Shandong University	Phase 4
Unknown	Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) NCT03199989	Peking University Cancer Hospital & Institute	Phase 3
Completed	Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma NCT03079427	Asan Medical Center	Phase 2
Terminated	TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients NCT02492477	Krankenhaus Barmherzige Schwestern Linz	Phase 1
Completed	Impact of Adjuvant Chemotherapy in Patients With Colon Cancer NCT03213444	University of Sao Paulo General Hospital	N/A
Unknown	Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer NCT01261962	University of Sao Paulo	N/A
Completed	Observational Study on the Patients With Rectal Cancer NCT02312284	Chinese Academy of Medical Sciences	—
Unknown	Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplant NCT01125020	Shanghai Jiao Tong University School of Medicine	N/A
Completed	Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma NCT06671431	Seoul National University Hospital	—
Completed	Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemoth NCT07521397	Hellenic Cooperative Oncology Group	—